Blog

We are excited to announce the addition phenibut, medetomidine, and tianeptine to our umbilical cord tissue, hair, and nail testing menus. These substances can be ordered as an individual test or an add-on to any umbilical cord tissue, hair, or nail drug panel beginning March 10, 2025.
Click here to learn more about our new phenibut, medetomidine, and tianeptine testing.
For more information on hair testing click here, for more information on nail testing click here, and for more information on umbilical cord tissue testing click here.
- USDTL’s Integration and Partnership With CourtFact
- New Year, New Capabilities: Offering Forensic & Clinical Testing Options
- Weather Delay
- The Detection of Delta-9-tetrahydrocannabinol, Delta-8-tetrahydrocannabinol, Delta-10-tetrahydrocannabinol, and Cannabidiol in Hair Specimens
- Umbilical Cord Tissue Testing for Ketamine
- Drugs of Abuse: A DEA Resource Guide (2024)
- Beyond THC and CBD: Understanding New Cannabinoids
- New Xylazine, Psilocin, Gabapentin, Dextromethorphan, and Extended Cannabinoids Testing at USDTL
- January 2026 (3)
- October 2025 (1)
- July 2025 (3)
- May 2025 (2)
- April 2025 (2)
- March 2025 (2)

